Neues Medikament bietet umfassenden Schutz vor HIV in Studie mit jungen afrikanischen Frauen

5 comments

1. This is groundbreaking news! The success of lenacapavir in providing total protection from HIV is a monumental step forward in global health, especially for young African women who are disproportionately affected. It’s incredible to see such advancements in prevention that can empower women and reduce the stigma around HIV. Hopefully, this leads to widespread availability and access. The fight against HIV/AIDS is far from over, but this is a huge leap in the right direction.

2. Sounds pretty monumental.

   > Researchers and activists in the trenches of the long fight against H.I.V. got a rare piece of exciting news this week: Results from a large clinical trial in Africa showed that a twice-yearly injection of a new antiviral drug gave young women total protection from the virus.

   > “I got cold shivers,” said Dr. Linda-Gail Bekker, an investigator in the trial of the drug, lenacapavir, describing the startling sight of a line of zeros in the data column for new infections. “After all our years of sadness, particularly over vaccines, this truly is surreal.”

   And they compared it directly against Truvada, a drug that significantly reduces HIV infection but must be taken daily.

   > The results were so convincing that the trial was halted early at the recommendation of the independent data review committee, which said all participants should be offered the injection because it clearly provided superior protection against the virus.

3. Let’s fucking go!

4. I am just… wow. Like there are so many words that I could string together to describe how monumental and amazing this would be if it really is the case, but I’m pretty speechless.

5. I wouldn’t volunteer